Campylobacter pylori and ulcer disease--a causal connection?
- PMID: 2683023
- DOI: 10.3109/00365528909091736
Campylobacter pylori and ulcer disease--a causal connection?
Abstract
A strong positive correlation has been demonstrated between the (antral mucosal) presence of Campylobacter pylori and active duodenal and gastric ulceration. Moreover, both duodenal and gastric ulcers heal, and remain in remission, as a consequence of therapeutic measures which eradicate C. pylori. However, the Henle-Koch postulates have not been fulfilled, because C. pylori has not been shown to produce ulcers. As for the claim that ulcer disease represents an infection with C. pylori because therapeutic eradication heals ulcers, it has been shown that antibiotics and metronidazole, as well as bismuth subcitrate, exert antiulcer actions by mechanisms which do not involve their antibacterial effects. The association between C. pylori and ulcer disease, which was noted half a century ago, remains unexplained now as it did then.
Similar articles
-
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S103-7. Eur J Gastroenterol Hepatol. 1994. PMID: 7735924 Clinical Trial.
-
Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial.Gut. 1988 Mar;29(3):279-83. doi: 10.1136/gut.29.3.279. Gut. 1988. PMID: 3356357 Free PMC article. Clinical Trial.
-
Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.Scand J Gastroenterol Suppl. 1989;157:16-20; discussion 21-2. doi: 10.3109/00365528909091046. Scand J Gastroenterol Suppl. 1989. PMID: 2568684 Review.
-
Cure of duodenal ulcer associated with eradication of Helicobacter pylori.Lancet. 1990 May 26;335(8700):1233-5. doi: 10.1016/0140-6736(90)91301-p. Lancet. 1990. PMID: 1971318 Clinical Trial.
-
The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.Scand J Gastroenterol Suppl. 1988;142:93-100. Scand J Gastroenterol Suppl. 1988. PMID: 3047854 Review.
Cited by
-
Helicobacter pylori in duodenal ulcer patients with idiopathic gastric acid hypersecretion.Dig Dis Sci. 1993 Jan;38(1):132-6. doi: 10.1007/BF01296785. Dig Dis Sci. 1993. PMID: 8420745
-
Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance.Dig Dis Sci. 2005 Feb;50(2):357-65. doi: 10.1007/s10620-005-1611-3. Dig Dis Sci. 2005. PMID: 15745101
-
Impairment of salivary mucin production resulting in declined salivary viscosity during naproxen administration as a potential link to upper alimentary tract mucosal injury.Clin Transl Gastroenterol. 2013 Jul 25;4(7):e40. doi: 10.1038/ctg.2013.8. Clin Transl Gastroenterol. 2013. PMID: 23884372 Free PMC article.
-
Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders.Dig Dis Sci. 2003 Feb;48(2):322-8. doi: 10.1023/a:1021983611768. Dig Dis Sci. 2003. PMID: 12643610 Clinical Trial.
-
Patients with Helicobacter pylori positive and negative duodenal ulcers have distinct clinical characteristics.World J Gastroenterol. 2005 Jun 21;11(23):3518-22. doi: 10.3748/wjg.v11.i23.3518. World J Gastroenterol. 2005. PMID: 15962366 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials